Dipyrone is a type of medicine used to treat pain, fever, and inflammation. It's also known by many other names, like Analgin, Algopyrin, or Metamizole. It works by affecting chemicals in your body that cause pain and fever. It's often used for things like headaches, muscle aches, or fever, but it should only be taken under a doctor's supervision.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Dipyrone, also called metamizole, is a non-opioid medicine for pain and fever. It is sold in many European, Latin American and Asian countries under names such as Novalgin, Nolotil and Analgin. Where it is authorized, it is used for moderate to severe pain, such as pain after surgery or an injury, cramping (colicky) pain and cancer-related pain, and for high fever that other measures have not controlled. In Germany it is the most commonly prescribed pain reliever. Dipyrone is not approved for human use in the United States. The US Food and Drug Administration (FDA) withdrew approval of all human dipyrone medicines in 1977 after reports of agranulocytosis, a rare but dangerous loss of infection-fighting white blood cells. It is also not approved in the United Kingdom or Canada. The only FDA-approved dipyrone product today is an injection for fever in horses, which is not for people. Any dipyrone product someone obtains in the US, or brings back from abroad, has not been reviewed by the FDA for human use.
Dipyrone is a prodrug: once swallowed, it is converted in the gut into active compounds that are absorbed into the blood. Pain relief usually begins within about 30 minutes and lasts around four hours, which is why it is taken several times a day. Exactly how it works is not fully understood. Its active compounds partly block cyclooxygenase (COX), the enzyme that makes prostaglandins, chemical signals that drive pain and fever, though more weakly than anti-inflammatory drugs such as ibuprofen. It also eases muscle spasm, which is why it is used for cramping pain. Laboratory studies suggest other pain pathways may be involved as well, but how much they matter in people is unclear.
Depending on the country, dipyrone comes as tablets, oral drops, suppositories and injections. In hospitals it is often given into a vein after surgery. In the European Union (EU), people aged 15 and older take no more than 1,000 mg at a time, up to four times a day (4,000 mg a day in total), and injected doses should not exceed 5,000 mg a day. Treatment starts at the lowest dose that may work. Children are dosed by body weight, and some product strengths are unsuitable for them. Short courses are preferred. Shorter use may lower the chance of serious blood problems, and longer, higher-dose use also increases interactions with other medicines. Because strengths, labeling and allowed uses differ from country to country, follow the instructions for the specific product rather than another person's routine.
Dipyrone is generally well tolerated. The more common problems are skin reactions such as itching, redness, hives or a rash, and sometimes nausea or an upset stomach. A drop in blood pressure can occur, particularly when it is given by injection. The most important risk is agranulocytosis. It is rare, but it can lead to severe or fatal infections. It does not depend on the dose, and it can start at any point during treatment or shortly after stopping, even in someone who has taken dipyrone before without problems. Its early signs are fever, chills, a sore throat, and painful sores in the mouth, nose or throat or in the genital or anal area. If any of these appear, stop dipyrone and get seen by a clinician right away (the same day) for a blood count. Someone who is very unwell with fever and chills needs emergency care. When dipyrone is being taken for fever, or alongside antibiotics, these early signs can be partly hidden, so a new sore throat or mouth sores deserve attention even if the fever seems controlled. Severe allergic reactions (anaphylaxis) are also rare but can be life-threatening, again even after earlier uneventful use. Trouble breathing, swelling of the face or throat, or feeling faint with widespread hives needs emergency care: call 911 or local emergency services. Rarely, dipyrone also injures the liver, including hepatitis and liver failure; yellowing of the skin or eyes or dark urine should be reported to a clinician right away.
Dipyrone must not be used by anyone who has had agranulocytosis from it or from related pyrazolone medicines (such as propyphenazone or phenylbutazone), or who has bone marrow problems, for example after chemotherapy, or a disease that affects how blood cells are made or work. In the EU it is not used in the last three months of pregnancy, because of possible effects on the baby's kidneys and circulation, or during breastfeeding, because a nursing infant can receive a large amount through milk. Little suggests harm in early pregnancy, but the evidence is limited, so anyone pregnant, planning pregnancy or breastfeeding should discuss alternatives. Dipyrone interferes with low-dose aspirin taken to protect the heart. It occupies the same site on platelets and can block aspirin's anti-clotting effect, and taking aspirin first does not reliably prevent this. People taking aspirin because of heart disease, a stent or a recent stroke should ask about a different pain reliever. Combining dipyrone with anti-inflammatory drugs such as ibuprofen is generally avoided because of added kidney, liver and blood risks. Taken at higher doses for more than about a day, dipyrone also speeds up the liver's breakdown of many other medicines, and this effect can last for weeks after stopping. It can lower levels of cyclosporine and tacrolimus (anti-rejection drugs after a transplant), several HIV medicines, the blood thinners apixaban (Eliquis) and rivaroxaban (Xarelto), methadone and some other opioid painkillers, and medicines such as sertraline (Zoloft, an antidepressant), quetiapine (Seroquel, an antipsychotic) and valproate (a seizure and mood-stabilizing medicine). Lower levels can make these medicines less effective, which matters most for transplant protection and clot prevention. It can make hormonal birth control less reliable for at least four weeks. Other medicines that can themselves lower white blood cells, such as clozapine (an antipsychotic), add to the agranulocytosis risk. Every prescriber and pharmacist should know about dipyrone use, including a product bought abroad.
For short-term pain, a dose usually starts working within about half an hour and lasts about four hours. In studies of pain after surgery, a single 500 mg dose gave at least half relief to about 70 of every 100 people, compared with about 30 of 100 on a placebo, although the trials were small. For fever in children, it worked about as well as ibuprofen in the few trials available. Routine blood tests are no longer recommended during treatment. Instead, safety depends on knowing the warning signs of agranulocytosis and acting on them, both while taking dipyrone and for a while after stopping, since the reaction can appear shortly after the last dose. If agranulocytosis does occur, dipyrone and related pyrazolone medicines should not be taken again. Dipyrone is available over the counter in many countries, so people who travel or live between countries may find it easy to buy. In the US there is no approved product, and the usual alternatives for pain and fever are acetaminophen and anti-inflammatory medicines such as ibuprofen or naproxen, each with its own trade-offs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Dipyrone, what you've noticed, or ask the community a question.